Domov › Rakovina prostaty › Nebraska
Klinické štúdie Rakovina prostaty v štáte Nebraska
27 štúdií pre Rakovina prostaty hľadá účastníkov v zariadeniach v štáte Nebraska.
Mestá v štáte Nebraska
Oficiálny text štúdie (anglicky)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- CHI Health Saint Francis, Grand Island
- CHI Health Good Samaritan, Kearney
- Alegent Health Immanuel Medical Center, Omaha
- a 2 ďalších
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Nebraska Medicine-Bellevue, Bellevue
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT03866382Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Urology Cancer Center, PC, Omaha
Prebieha náborFáza 1/2
Vek 18 a viac · Muži · Aktualizované 25. 9. 2026 · NCT06800313A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0026), Omaha
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06136650Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Nebraska Cancer Specialists, Omaha
Prebieha náborFáza 2/3
Vek 18 až 100 · Muži · Aktualizované 22. 9. 2026 · NCT06780670Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Nebraska Cancer Specialists, Omaha
Prebieha náborFáza 3
Vek 18 až 100 · Muži · Aktualizované 22. 9. 2026 · NCT06855277PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer
- University of Nebraska Medical Center, Omaha
Prebieha náborFáza 2
Vek 30 a viac · Muži · Aktualizované 21. 9. 2026 · NCT07234981A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- XCancer, Omaha
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 15. 9. 2026 · NCT07581184Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- XCancer Omaha LLC, Omaha
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 11. 9. 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Nebraska Medicine-Bellevue, Bellevue
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 10. 9. 2026 · NCT05946213Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Research Site, Omaha
Prebieha náborFáza 1/2
Vek 18 až 99 · Muži · Aktualizované 27. 8. 2026 · NCT07590934AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Omaha
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 26. 8. 2026 · NCT07611110Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- XCancer Omaha, Omaha
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 24. 8. 2026 · NCT07745361A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Nebraska Cancer Specialists, Omaha
Prebieha náborFáza 1/2
Vek 18 a viac · Muži · Aktualizované 20. 8. 2026 · NCT06785636Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- CHI Health Good Samaritan, Kearney
- Alegent Health Bergan Mercy Medical Center, Omaha
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 19. 8. 2026 · NCT04423211Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
- University of Nebraska Medical Center, Omaha
Prebieha náborFáza 2
Vek 30 a viac · Muži · Aktualizované 19. 8. 2026 · NCT07237269Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- CHI Health Saint Francis, Grand Island
- CHI Health Good Samaritan, Kearney
- Alegent Health Immanuel Medical Center, Omaha
- a 2 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 14. 7. 2026 · NCT06592924Integrated Cancer Repository for Cancer Research
- Mary Lanning Healthcare, Morrison Cancer Center, Hastings
- Faith Regional Health Services, Carson Cancer Center, Norfolk
- Great Plains Regional Medical Center, North Platte
- a 3 ďalších
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 19 až 110 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT02012699Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Nebraska Cancer Specialists (Midwest Cancer Center - Legacy), Omaha
- XCancer Omaha / Urology Cancer Center, Omaha
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 6. 2026 · NCT05283330Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Urology Cancer Center PC, Omaha
- Nebraska Cancer Specialists, Omaha
Prebieha náborFáza 4
Vek 18 až 100 · Muži · Aktualizované 4. 6. 2026 · NCT05803941Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
- XCancer Omaha / Urology Cancer Center, Omaha
Prebieha náborFáza 1/2
Vek 18 a viac · Muži · Aktualizované 14. 5. 2026 · NCT05413850A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Research Site, Omaha
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 12. 5. 2026 · NCT06879041Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- CHI Health Good Samaritan, Kearney
- Saint Elizabeth Regional Medical Center, Lincoln
- Alegent Health Immanuel Medical Center, Omaha
- a 4 ďalších
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 29. 1. 2026 · NCT05806515Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Nebraska Medicine-Bellevue, Bellevue
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 22. 1. 2026 · NCT06470243High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer
- University of Nebraska Medical Center, Omaha
Prebieha nábor
Vek 19 a viac · Muži · Aktualizované 5. 11. 2025 · NCT05754580SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Omaha
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Nebraska Medicine-Bellevue, Bellevue
- Nebraska Methodist Hospital, Omaha
- Nebraska Medicine-Village Pointe, Omaha
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 11. 9. 2025 · NCT03678025Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.